21 Results for "

MPT

" in MedChemExpress (MCE) Product Catalog:
Products (21)

21 Results for "MPT" in MCE Product Catalog:

Art. -Nr.: HY-163269
CAS. Nr.: 2413282-48-9
Target:  

Bacterial

Forschungsgebiete:  

Others

MPT is a novel and highly efficient nitrification inhibitor. MPT inhibits ammoniaoxidizing bacteria and archaea .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-123976
CAS. Nr.: 2151853-97-1
Reinheit:  99.79%
Target:  

HDAC

Forschungsgebiete:  

Neurological Disease Cancer

MPT0G211 is a potent, orally active and selective HDAC6 inhibitor (IC50=0.291 nM). MPT0G211 displays >1000-fold selective for HDAC6 over other HDAC isoforms. MPT0G211 can penetrate the blood-brain barrier. MPT0G211 ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model. MPT0G211 has anti-metastatic and neuroprotective effects. Anticancer activities .
loading...
    loading...
Art. -Nr.: HY-124295
CAS. Nr.: 1338320-94-7
Reinheit:  99.40%
Synonyms: ABT-301; MPT0E028; TMU-C-0012
Target:  

HDAC Akt Apoptosis

Forschungsgebiete:  

Inflammation/Immunology Cancer

Imofinostat (ABT-301; MPT0E028) is an orally active and selective HDAC inhibitor with IC50s of 53.0 nM, 106.2 nM, 29.5 nM for HDAC1, HDAC2 and HDAC6, respectively. Imofinostat has a weak inhibitory effect on HDAC8 (IC50 of 2.5 ​​μM), but no inhibitory effect on HDAC4 (IC50>10 μM). Imofinostat reduces the viability of B-cell lymphomas by inducing apoptosis and possesses potent direct Akt targeting ability and reduces Akt phosphorylation in B-cell lymphoma. Imofinostat has a broad-spectrum antitumor activity, including colorectal cancer, B-cell lymphoma, non-small cell lung carcinoma (NSCLC), and pancreatic cancer, while also showing therapeutic potential in non-tumor diseases like emphysema and pulmonary fibrosis .
loading...
    loading...
Art. -Nr.: HY-P3101
CAS. Nr.: 1225021-13-5
Target:  

GCGR

Forschungsgebiete:  

Cardiovascular Disease Metabolic Disease

GLP-1(28-36)amide, a C-terminal nonapeptide of GLP-1, is a major product derived from the cleavage of GLP-1 by the neutral endopeptidase (NEP). GLP-1(28-36)amide is an antioxidant and targets to mitochondrion, inhibits mitochondrial permeability transition (MPT). GLP-1(28-36)amide has anti-diabetic and cardioprotection effects .
loading...
    loading...
Art. -Nr.: HY-145426
CAS. Nr.: 1817802-18-8
Reinheit:  98.76%
Target:  

HDAC

Forschungsgebiete:  

Cancer

MPT0B390 is an arylsulfonamide-based derivative with potent HDAC inhibitory ability. MPT0B390, TIMP3 inducer, inhibits tumor growth, metastasis and angiogenesis. MPT0B390 shows antiproliferative activity against human colon cancer cell line HCT116 with the GI50 of 0.03 μM .
loading...
    loading...
Art. -Nr.: HY-120786
CAS. Nr.: 1215208-59-5
Reinheit:  99.67%
Synonyms: 6-(3′,4′,5′-Trimethoxybenzoyl)quinoline
Forschungsgebiete:  

Cancer

MPT0B014 is a tubulin polymerization inhibitor. MPT0B014 induces cancer cell apoptosis. MPT0B014 can be used for the research of cancer .
loading...
    loading...
Art. -Nr.: HY-101287
CAS. Nr.: 1346169-92-3
Reinheit:  99.63%
Forschungsgebiete:  

Cancer

MPT0B392, an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation, leading to apoptosis. MPT0B392 inhibits tubulin polymerization and triggers induction of the mitotic arrest, followed by mitochondrial membrane potential loss and caspases cleavage by activation of JNK and ultimately leads to apoptosis. MPT0B392 is demonstrated to be a novel microtubule-depolymerizing agent and enhances the cytotoxicity of sirolimus in sirolimus-resistant acute leukemic cells and the multidrug resistant cell line .
loading...
    loading...
Art. -Nr.: HY-122888
CAS. Nr.: 2070837-24-8
Forschungsgebiete:  

Cancer

MPT0L145 is a PIK3C3/FGFR inhibitor, with a Kd value of 0.53 nM for PIK3C3. MPT0L145 decreases the phosphorylation of FGFR1, FGFR3 and their downstream proteins (FRS2, ERK and Akt). MPT0L145 induces G0/G1 cell cycle arrest and decreased protein levels of cyclin E. MPT0L145 promotes mitochondrial dysfunction, ROS production, and DNA damage. MPT0L145 is an autophagy inhibitor. MPT0L145 significantly sensitizes cancer cells to targeted or chemotherapeutic agents. MPT0L145 can be used for cancer research, such as bladder cancer and NSCLC .
loading...
    loading...
Art. -Nr.: HY-141541
CAS. Nr.: 2241643-23-0
Target:  

HDAC Tau Protein

Forschungsgebiete:  

Neurological Disease

MPT0G413 (Compound 6) is a potent, selective, orally active and brain-penetrant HDAC6 inhibitor with an IC50 of 3.92 nM. MPT0G413 decreases not only the level of phosphorylation of tau proteins but also the aggregation of tau proteins. MPT0G413 can ameliorate the impaired learning and memory. MPT0G413 can be used for the research of neurological disease, such as Alzheimer's disease .
loading...
    loading...
Art. -Nr.: HY-P2996B
CAS. Nr.: 9029-27-0
Target:  

Others

Forschungsgebiete:  

Others

Nitrate Reductase (NAD[P]H), Pichia pastoris (recombinant) is a simplified version of nitrate reductase S-NaR1 expressed and purified by Pichia pastoris. Nitrate Reductase (NAD[P]H), Pichia Pastoris (recombinant) contains sites binding molybdenum-molybdenopyridine (Mo-MPT) and nitrate reduction active sites and only contains two domains instead of the five domains of the complete NaR. This simplified form of nitrate reductase was expressed in high density in P. pastoris and purified to homogeneity in one step by fixed metal affinity chromatography (IMAC). Nitrate Reductase (NAD[P]H), Pichia Pastoris (recombinant) can be used in the development of biosensors and environmental monitoring .
loading...
    loading...
Art. -Nr.: HY-138289
CAS. Nr.: 2173386-55-3
Target:  

Drug Derivative

Forschungsgebiete:  

Neurological Disease

4-acetoxy MPT is a tryptamine that induces the head-twitch response (HTR) in mice .
loading...
    loading...
Art. -Nr.: HY-D0129
CAS. Nr.: 82962-86-5
Synonyms: MPTS
Target:  

Fluorescent Dye

Forschungsgebiete:  

Others

8-Methoxypyrene-1,3,6-trisulfonate trisodium (MPTS) is a highly water-soluble superpolar fluorescent probe .
loading...
    loading...
Art. -Nr.: HY-170053
CAS. Nr.: 763035-03-6
Synonyms: 4-OH-MPT; Meprocin
Target:  

5-HT Receptor

Forschungsgebiete:  

Neurological Disease

4-Hydroxy MPT (4-OH-MPT), a serotonergic hallucinogen, is a 5-HT2A and 5-HT2B receptors agonist with EC50 values of 3.82 nM and 3.4 nM, respectively .
loading...
    loading...
Art. -Nr.: HY-123976A
CAS. Nr.: 2151854-33-8
Target:  

HDAC

Forschungsgebiete:  

Neurological Disease Cancer

MPT0G211 mesylate is a potent, orally active and selective HDAC6 inhibitor (IC50=0.291 nM). MPT0G211 mesylate displays >1000-fold selective for HDAC6 over other HDAC isoforms. MPT0G211 mesylate can penetrate the blood-brain barrier. MPT0G211 mesylate ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model. MPT0G211 mesylate has anti-metastatic and neuroprotective effects. Anticancer activities .
loading...
    loading...
Art. -Nr.: HY-124083
CAS. Nr.: 1215208-65-3
MPT0B214 is a microtubule inhibitor that strongly binds to the colchicine binding site of tubulin, preventing tubulin polymerization. MPT0B214 induces apoptosis through a mitochondrial/caspase 9 dependent pathway and shows cytotoxicity across various human tumor cell lines. MPT0B214 can be used for cancer research .
loading...
    loading...
Art. -Nr.: HY-122151
CAS. Nr.: 946077-08-3
Forschungsgebiete:  

Cancer

MPT0B002 is a potent microtubule inhibitor with anticancer activities. MPT0B002 disrupts tubulin polymerization, induces apoptosis, and arrests cell cycle at the G2/M phase .
loading...
    loading...
Art. -Nr.: HY-P3101A
Target:  

GCGR

Forschungsgebiete:  

Cardiovascular Disease Metabolic Disease

GLP-1(28-36)amide TFA, a C-terminal nonapeptide of GLP-1, is a major product derived from the cleavage of GLP-1 by the neutral endopeptidase (NEP). GLP-1(28-36)amide TFA is an antioxidant and targets to mitochondrion, inhibits mitochondrial permeability transition (MPT). GLP-1(28-36)amide TFA has anti-diabetic and cardioprotection effects .
loading...
    loading...
Art. -Nr.: HY-101287R
CAS. Nr.: 1346169-92-3
Forschungsgebiete:  

Cancer

MPT0B392 (Standard) is the analytical standard of MPT0B392 (HY-101287). This product is intended for research and analytical applications. MPT0B392, an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation, leading to apoptosis. MPT0B392 inhibits tubulin polymerization and triggers induction of the mitotic arrest, followed by mitochondrial membrane potential loss and caspases cleavage by activation of JNK and ultimately leads to apoptosis. MPT0B392 is demonstrated to be a novel microtubule-depolymerizing agent and enhances the cytotoxicity of sirolimus in sirolimus-resistant acute leukemic cells and the multidrug resistant cell line .
loading...
    loading...
Art. -Nr.: HY-124595
CAS. Nr.: 1254363-89-7
MPT0B098 is a microtubule inhibitor with a Ki of 0.8 μM and an IC50 of 0.8 μM. MPT0B098 inhibits tubulin polymerization, blocks HuR nuclear-cytoplasmic translocation to decrease HIF-1α mRNA stability, suppresses HIF-1α, TGF-β/Smad, JAK2/STAT3 and FAK/actin cytoskeleton signaling pathways, upregulates SOCS3 to reinforce the inhibition of JAK2/STAT3 cascade, and induces apoptosis. MPT0B098 can be used for research on multiple malignancies including head and neck squamous cell carcinoma and human non-small cell lung cancer .
loading...
    loading...
Art. -Nr.: HY-P705686
Reinheit:  ≥ 85%, as determined by reducing SDS-PAGE .
Synonyms: Immunogenic protein MPT64; Antigen MPT64; MPT64; MTCY39.39; Rv1980c
Species:  
Human
Source:  
E. coli
loading...
    loading...